TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable” April 23, 1982
TCL Archive In Brief: WHO Begins Project To Urge Governments To Establish “National Cancer Programs” October 30, 1998